Literature DB >> 1084215

Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption.

P B Neame, J Hirsh, G Browman, J Denburg, T J D'Souza, A Gallus, M C Brain.   

Abstract

In four of five patients with thrombotic thrombocytopenic purpura (TTP) in whom serial tests of hemostatic function were performed, severe thrombocytopenia, normal plasma fibrinogen concentrations and mildly increased concentrations of fibrinogen/fibrin degradation products were observed. Widespread platelet thrombi were found in arterioles and capillaries. Fibrin could be seen around some of the platelet clumps and was the main component in a small number of the thrombi in two patients. The observations show that TTP is a disorder in which intravascular platelet consumption results in disseminated platelet thrombosis. The coagulation system is apparently activated secondarily to platelet aggregation and variable quantities of fibrin are incorporated into the thrombi. Clinical improvement resulted from combined therapy with corticosteroids, heparin and drugs that suppress platelet function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084215      PMCID: PMC1957151     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  24 in total

1.  The nature of the hyaline thrombi in thrombotic thrombocytopenic purpura.

Authors:  J M CRAIG; D GITLIN
Journal:  Am J Pathol       Date:  1957 Mar-Apr       Impact factor: 4.307

2.  Thrombotic thrombocytopenic purpura; remission after splenectomy.

Authors:  H F RODRIGUEZ; D F BABB; E PEREZ SANTIAGO; J COSTAS-DURIEUX
Journal:  N Engl J Med       Date:  1957-11-14       Impact factor: 91.245

3.  The vascular pathology of thrombotic thrombocytopenic purpura. An immunohistochemical and ultrastructural study.

Authors:  J D Feldman; M R Mardiney; E R Unanue; H Cutting
Journal:  Lab Invest       Date:  1966-06       Impact factor: 5.662

4.  Resolution and organization of platelet-rich mural thrombi in carotid arteries of swine.

Authors:  L Jorgensen; H C Rowsell; T Hovig; J F Mustard
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

5.  Aspirin and prednisone in microangiopathic haemolytic anaemia.

Authors:  F Jobin; J M DeLage
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

6.  Thrombotic thrombocytopenic purpura; treatment with antiplatelet agents.

Authors:  G B Faguet; M B King
Journal:  Am J Med Sci       Date:  1974-08       Impact factor: 2.378

7.  Platelets and initiation of intrinsic clotting.

Authors:  S Schiffman; S I Rapaport; M M Chong
Journal:  Br J Haematol       Date:  1973-05       Impact factor: 6.998

8.  Platelet and fibrinogen consumption in man.

Authors:  L A Harker; S J Slichter
Journal:  N Engl J Med       Date:  1972-11-16       Impact factor: 91.245

9.  Thrombotic thrombocytopenic purpura. Remission following hemodialysis.

Authors:  A P Tartaglia; P T Burkart
Journal:  JAMA       Date:  1971-11-15       Impact factor: 56.272

10.  Thrombotic thrombocytopenic purpura: report of a case with possible immune etiology.

Authors:  M J Mant; M N Cauchi; G Medley
Journal:  Blood       Date:  1972-09       Impact factor: 22.113

View more
  3 in total

1.  Thrombotic thrombocytopenic purpura.

Authors:  W J Gundlach; R Tarnasky
Journal:  Can Med Assoc J       Date:  1976-12-18       Impact factor: 8.262

Review 2.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

3.  [Thrombotic thrombocytopenic purpura].

Authors:  C Aul; R E Scharf; T Königshausen; W Schneider
Journal:  Klin Wochenschr       Date:  1985-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.